Towards characteristics of photodynamic drugs specifically aimed at microvascular diseases

Mini-Reviews in Medicinal Chemistry

Volumn 10, Issue 4, 2010, Pages 332-341

  Zhao, Jingquan ^a   Deng, Hong ^a   Xie, Jie ^a   Liu, Xin ^a   Zhang, Yang ^a   Huang, Naiyan ^b   Gu, Ying ^b  

^a INSTITUTE OF CHEMISTRY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Biological activity; Drug delivery; Drug preparation; Microvascular disease; Photodynamic therapy (pdt); Photosensitizers; Solid tumor; Target related characteristic drug

Indexed keywords

HEMATOPORPHYRIN; HYPOCRELLIN A; HYPOCRELLIN B; PHOTOSENSITIZING AGENT; VERTEPORFIN;

ANTIANGIOGENIC THERAPY; ARTICLE; CELL DEATH; DRUG USE; HUMAN; MICROANGIOPATHY; NEVUS FLAMMEUS; PHOTOCHEMOTHERAPY; RADIATION EXPOSURE; RETINA MACULA AGE RELATED DEGENERATION; ANIMAL; DRUG EFFECT; METHODOLOGY; MICROVASCULATURE; REVIEW; VASCULAR DISEASE;

ANIMALS; HUMANS; MICROVESSELS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; VASCULAR DISEASES;

EID: 77956623686     PISSN: 13895575     EISSN: 18755607     Source Type: Journal    
DOI: 10.2174/138955710791330963     Document Type: Article

References (77)

1. Grossweiner, L.I. In the Science of Phototherapy: An Introduction; Linda R. Jones, Ed.; Springer: Netherlands, 2005; pp. 1-8.
2. Lu, Z.; Tao, Y.; Zhou, Z.; Zhang, J.; Li, C.; Ou, L.; Zhao, B. Mitochondrial reactive oxygen species and nitric oxide-mediated cancer cell apoptosis in 2-butylamino-2-demethoxyhypocrellin B photodynamic treatment. Free Radic. Biol. Med., 2006, 41, 1590-1605.
3. Flors, C.M.; Fryer, J.; Waring, J.; Reeder, B.; Bechtold, U.; Mullineaux, P.M.; Nonell, S.; Wilson, M.T.; Baker, N.R. Imaging the production of singlet oxygen in vivo using a new fluorescent sensor, Singlet Oxygen Sensor Green®. J. Exp. Bot., 2006, 57, 1725-1734.
4. Takeda, A.; Baffi, J.Z.; Kleinman, M.E.; Cho, W.G.; Nozaki, M.; Yamada, K.; Kaneko, H.; Albuquerque, R.J.; Dridi, S.; Saito, K.; Raisler, B.J.; Budd, S.J.; Geisen, P.; Munitz, A.; Ambati, B.K.; Green, M.G.; Ishibashi, T.; Wright, J.D.; Humbles, A.A.; Gerard, C.J.; Ogura, Y.; Pan, Y.; Smith, J.R.; Grisanti, S.; Hartnett, M.E.; Rothenberg, M.E.; Ambati, J. CCR3 is a target for age-related macular degeneration diagnosis and therapy. Nature, 2009, 460, 225-230.
5. Benedito, R.; Roca, C., Sörensen, I., Adams, S.; Gossler, A.; Fruttiger, M.; Adams, R.H. The notch ligands Dll4 and jagged1 have opposing effects on angiogenesis p1124. Cell, 2009, 137, 1124-1135.
6. Dewhirst, M.W.; Navia, I.C.; Brizel, D.M. Multiple etiologies of tumor hypoxia require multifaceted solutions. Clin. Cancer Res., 2007, 13, 375-377.
7. Mulliken, J.L.; Young, A.E. Vascular Birthmarks-Hemangiomas and Malformations, WB Saunders: Philadelphia, 1988.
8. Ambati, J.; Ambati, B.K.; Yoo, S.H.; Lanchulev, S.; Adamis, A.P. Age-related macular degeneration: Etiology, pathogenesis, and therapeutic strategies. Surv. Ophthalmol. 2003, 48, 257-293.
9. Dennis, E.J.; Dolmans, G.J.; Fukumura, D.R.; Jain, K. Photodynamic therapy for cancer. Nat. Rev. Cancer, 2003, 3, 380-387.
10. Castano, A.P.; Mroz, P.M.; Hamblin, R. Photodynamic therapy and anti-tumour immunity. Nat. Rev. Cancer, 2006, 6, 535-545.
11. Bergh, H.V.D. Photodynamic therapy of age-related macular degeneration: History and principles. Semin. Opthalmol., 2001, 16, 181-200.
12. Nielsen, K.P.; Juzeniene, A.; Juzenas, P. Choice of optimal wavelength for PDT: the significance of oxygen depletion. Photochem. Photobiol., 2005, 81, 1190-1194.
13. Christophe, H.; Georges, W.; Philippe, M.; Hubert, B. EPR and spectrophotometric studies of free radicals (O-2 center dot(-), center dot OH, BPD-MA center dot(-)) and singlet oxygen (O-1(2)) generated by irradiation of benzoporphyrin derivative monoacid ring A. Photochem. Photobiol., 1997, 65, 818-827.
14. Shopova, M.; Mantareva, V.; Krastev, K.; Hadjiolov, D.; Milev, A.; Spirov, K.; Jori, G.; Ricchelli, F. Comparative pharmacokinetic and photodynamic studies with zinc (II) phthalocyanine in hamsters bearing an induced or transplanted rhabdomyosarcoma. J. Photochem. Photobiol. B:Biol., 1992, 16, 83-89.
15. Wang, L.; Gu, Y.; Li, X.S.; Liu, F.G.; Yu, C.Q. Monitoring of photodynamic therapy of port wine stain by fluorescence Spectroscopy. Spectrosc. Spectral Anal., 2007, 27, 1788-1792.
16. Dolmans, D.; Fukumura, D.; Jain, R.K. Photodynamic therapy for cancer. Nat. Rev. Cancer, 2003, 3, 380-387.
17. Barclay, L.R.C.; Basque, M.C.; Stephenson, V.C.; Vinqvist, M.R. Photooxidations initiated or sensitized by biological molecules: Singlet oxygen versus radical peroxidation in micelles and human blood plasma. Photochem. Photobiol., 2003, 78, 248-255.
18. Erin, M.; Barbara, J.M.; Kozlowski, M.C. Dynamic stereochemistry transfer in a transannular aldol reaction: Total synthesis of hypocrellin A. Angew. Chem. Int. Ed., 2008, 47, 6877-6880.
19. Li, C.; Chen, Y.T.; Tai, H.; Ou, L.C. Biological synthesis of perylenoquinone compounds. CN. Patent 200510010612.X, 2005.
20. Miller, G.G.; Brown, K.; Ballangrud, A.M.; Barajas, O.; Xiao, Z.; Tulip, John.; Lown, J. W.; Leithoff, J. M.; Allalunis-Turner, M.J.; Mehta, R.D.; Moore, R.B. Preclinical assessment of hypocrellin B and hypocrellin B derivatives sensitizers for photodynamic therapy of cancer: progress update. Photochem. Photobiol., 1997, 65, 714-722.
21. Hudson, J.B.; Imperial, V.; Haugland, R.P.; Diwu, Z. Antiviral activities of photoactive perylenequinones. Photochem. Photobiol., 1997, 65, 352-354.
22. Wang, Z.J.; He, Y.Y.; Huang, C.G.; Huang, J.S.; Huang, Y. Cai.; An, J.Y.; Gu, Y.; Jiang, L.J. Pharmacokinetics, tissue distribution and photodynamic therapy efficacy of liposomal-delivered hypocrellin A, a potential photosensitizer for tumor therapy. Photochem. Photobiol., 1999, 70, 773-780.
23. Xu, S.J.; Chen, S.; Zhang, M.H.; Shen, T. Hypocrellin derivative with improvements of red absorption and active oxygen species generation. Bioorg. Med. Chem. Lett., 2004, 14, 1499-1501.
24. Li, L.; Chen, Y.W.; Zhang, M.H.; Shen, T. New long-wavelength perylenequinones: synthesis and phototoxicity of hypocrellin B derivatives. Biochim. Biophys. Acta, 2000, 1523, 6-12.
25. Ma, J., Zhao, J.Q., Jiang, L.J. Effect of structural modification on photodynamic activities of hypocrellins. Photochem. Photobiol., 2001, 74(2), 143-148.
26. Diwu, Z.J.; Haugland, R.P.; Liu, J.X.; William Lown, J.; Miller, G.G.; Moore, R.B.; Brown, K.; Tulip, J.; McPhee, M.S. Photosensitization by anticancer agents: New perylene-and aminonaphthoquinones. Free Radic. Biol. Med., 1996, 20, 589-593.
27. Li, L.; Shen, Y. W.; Shen, J. Q.; Zhang, M. H.; Shen, T. New longwavelength perylenequinones: synthesis and phototoxicity of hypocrellin B derivatives. Biochem. Biophys. Acta, 2000, 1523, 6-12.
28. Li, C.; He, Y. P.; Ou, L. C.; Tian, M. J.; Yao, Z.; Guo, M. B. Photophysical and photosensitive properties of Elsinochrome A. Chin. Sci. Bull., 2006, 51, 1050-1054.
29. Diwu, Z. J.; Lown, J. W. Photosensitization by anticancer agents.12.perylene quinonoid pigments, a novel type of singlet oxygen sensitizer. J. Photochem. Photobiol. A., 1992, 64, 273-287.
30. Brown, D.M.; Michels, M.; Kaiser, P.K. J.S.; Heier, J.P. Ranibizumab versus verteporfin photodynamic therapy for neovascular agerelated macular degeneration: Two-Year results of the ANCHOR study. Ophthalmology, 2009, 116, 57-65.
31. Saito, M.; Iida, T.; Nagayama, D. Photodynamic therapy with verteporfin for age-related macular degeneration or polypoidal choroidal vasculopathy: comparison of the presence of serous retinal pigment epithelial detachment. Br. J. Ophthalmol., 2008, 92, 1642-1647.
32. Zhao, K.H.; Jiang, L.J. Structural changes of hypocrellin A in alkali and neutral solution. Chin. J. Chem., 1989, 9, 252-254.
33. Ma, L.; Tai, H.; Li, C. Photodynamic inhibitory effects of three perylenequinones on human colorectal carcinoma cell line and primate embryonic stem cell line. World J. Gastroenterol., 2003, 9, 485-490.
34. Diwu, Z. J.; Lown, J.W. Photosensitization by anticancer agents.12.perylene quinonoid pigments, a novel type of singlet oxygen sensitizer. J. Photochem. Photobio. A, 1992, 64, 273-287.
35. Smirnov, A.; Fulton, D.B.; Andreotti, A.; Petrich, J.W. Exploring ground-state heterogeneity of hypercin and hypocrellin A and B: Dynamic and 2D ROESY NMR study. J. Am. Chem. Soc., 1999, 121, 7979-7088.
36. Xu, S.J.; Chen, S.; Zhang, M.H.; Shen, T. First synthesis of methylated Hypocrellin and its fluorescent excited state: A cautionary tale. J. Org. Chem., 2003, 68, 2048-2050.
37. Song, L.M.; Xie, J.; Zhang, C.X.; Li, C.; Zhao, J.Q. Recognition of various biomolecules by the environment-sensitive spectral responses of hypocrellin B. Photochem. Photobiol. Sci., 2007, 6, 683-688.
38. Zhao, B.Z.; Xie, J.; Zhao, J.Q. Spectroscopic studies of the interaction between hypocrellin B and human serium albumin. Bioorg. Med. Chem., 2006, 14, 2428-2432.
39. Song, L.M.; Xie, J.; Zhao, J.Q. Interactions of Hypocrellin B with hyaluronan and Photo-induced interactions. Biochim. Biophys. Acta, 2006, 1760, 333-339.
40. Zhao, B.Z.; Xie, J.; Zhao, J.Q. Binding of hypocrellin B to human serum albumin and photo-induced interactions. Biochim. Biophys. Acta, 2005, 1722,124-130.
41. Liu, H.L.; Liu, F.G.; Gu, Y.; Zhao, J.Q.; Ma, J.H.; Zen, J.; Pan, Y.M. Photocytotoxicity characteristics of three photosensitizers induced by copper vapor laser irradiation. Chin. J. Laser Med. Surg., 2003, 12, 151-155. (In Chinese with English abstract).
42. Liu, H.L.; Liu, F.G.; Gu, Y.; Ma, J.H.; Zhao, J.Q.; Zen, J.; Li, X.S. An experimental study of photodynamic effect of hypocrellin B on Leghorn cock comb. Chin. J. Laser Med. Surg., 2005, 14, 1-5. (In Chinese with English abstract).
43. Liu, F.G.; Han, L.N.; Gu, Y.; Zhang, L.; Chen, H.X. Biological features of the choriocapillaries after hypocrellin B photodynamic therapy. Chin. J. Clin. Rehabilitation, 2005, 9, 254-256. (in Chinese).
44. Zhang, L.; Gu, Y.; Liu, F.G.; Liu, Y.Y.; Zhao, X.M.; Zen, J.; Han, L.N.; Dai, W.D. Effect of photodynamic therapy on rat mesenteric microcirculation. Chin. J. Laser Med. Surg., 2003, 12, 69-75. (in Chinese)
45. Khoobehi, B.; Grinstead, R.; Passos, E. Experimental science: experimental photodynamic effects of hypocrellin a on the choriocapillaris. Ophthalmic Surg. Lasers, 2002, 33, 207-213.
46. Estey, E.; Brown, K.; Wu, Z.D.; Liu, J.X.; Lown, J.W.; Miller, G.G.; Moore, R.B. Tulip, J.; McPhee, M.S. Hypocrellins as photosensitizers for photodynamic therapy: a screening evaluation and pharmacokinetic study. Cancer Chemother. Pharmacol., 1996, 37, 343-350.
47. Wu, Z.D.; Lown, J.W. Hypocrellins and their use in photosensitization (review). Photochem. Photobiol., 1990, 52, 609-616.
48. Immordino, M.L.; Dosio, F.; Cattel, L. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. Int. J. Nanomed., 2006, 1, 297-315.
49. Torchilin, V.; Weissig, V. Liposomes-A Practical Approach, Oxford University Press: New York, 2nd ed.; 2003.
50. Chowdhary, R.K.; Sharif, I.; Chansarkar, N.; Dolphin, D. Correlation of photosensizitizer delivery to lipoproteins and efficiency in tumor and arthritis mouse models; Comprison of lipid-based and pluronic P123 formulations. J. Pharm. Pharmaceut. Sci., 2003, 6, 198-204.
51. Zhao, J.Q.; Zhang, Y.; Xie, J. A method of Preparing solid liposomal hypocrellins. CN. Patent 200710120727.3, 2007
52. Zhao, J.Q.; Le, X.Y.; Xie, J.; Gu, Y. A method of Preparing solid liposome hypocrellins. CN. Patent 2003148147.7, 2003.
53. Zhao, B.Z.; Xie, J.; Zhao, J.Q. A novel water-soluble nanoparticles of hypocrellin B and their interaction with a model protein - Cphycocyanin. Biochim. Biophys. Acta, 2004, 1670, 113-120.
54. Zhao, J.Q.; Liu, X.; Gu, Y.; Li, L.H. Preparation and application of the oil-emulsion of hypocrellins. CN. Patent 200610001677.2, 2006;
55. Hu, Y.Z.; An, J.Y.; Jiang, L.J. Studies of the sulfonation of hypocrellin-a and the photodynamic actions of the product. J. Photochem. Photobiol. B:Biol., 1993, 17, 195-201.
56. He, Y.Y.; An, J.Y.; Jiang, L.J. Glycoconjugated hypocrellin: synthesis of [(beta-D-glucosyl)ethylthiyl]hypocrellins and photosensitized generation of singlet oxygen. Biochim. Biophys. Acta, 1999, 1472, 232-239.
57. He, Y.Y.; An, J.Y.; Zhou, W.; Jiang, L.J. Photoreactions of hypocrellins B with thiol compounds. J. Photochem. Photobiol. B:Biol., 1998, 44, 45-52.
58. Ou, Z.Z.; Chen, J.R.; Wang, X.S.; Zhang, B.W.; Cao, Y. Synthesis of a water-soluble cyclodextrin modified hypocrellin and ESR study of its photodynamic therapy properties. New J. Chem., 2002, 26, 1130-1136.
59. He, Y.Y.; Liu, H.Y.; An, J.Y. Jiang, L.J. Photodynamic action of hypocrellin dyes: structure-activity relationships. Dyes Pigm., 1999, 44, 63-67.
60. Wu, T.; Xu, S.J.; Shen, J.Q.; Song, A.M.; Chen, S.; Zhang, M.H.; Shen, T. New potential photodynamic therapeutic anti-cancer agents: synthesis and characterization of demethoxy aminosubstituted hypocrellins. Anticancer Drug Des., 2000, 15, 287-293.
61. Min, W.; Zhang, M.H.; Ma, L.; Shen, T.; Jiang, L.J. New longwavelength perylenequinones. The reaction between hypocrellin B and mercapto compounds. Dyes Pigm., 1997, 35, 297-310.
62. Song, Y.Z.; An, J.Y.; Jiang, L.J. ESR evidence of the photogeneration of free radicals and siglet oxygen by 15-deacetyl-13-glycinesubstituted hypocrellin B. Biochem. Biophys. Acta, 1999, 1472, 307-313.
63. Zhao, Y.W.; Xie, J.; Ma, J.S.; Zhao, J.Q. A novel amphiphilic 2- taurine substituted hypocrellin B (THB) and its photodynamic activity. New J. Chem., 2004, 28, 486-491.
64. Liu, X.; Xie, J.; Zhao, J.Q. Optimization of hypocrellin B derivative amphiphilicity and biological activity. Chin. Sci. Bull., 2009, 54, 2045-2050.
65. Liu, X. Ph.D. Thesis, Institute of Chemistry Chinese Academy of Sciences, 2008.
66. Weng, M.; Zhang, M.H.; Shen, T. Investigation of triplet states and radical anions produced by laser photoexcitation of hypocrellins. J. Chem. Soc. Faraday trans., 1997, 93, 3491-3495.
67. He, Y.Y.; An, J.Y.; Jiang, L.J. Synthesis and ESR investigation of hypocrellin glycoside. Tetrahedron Lett., 1998, 39, 5069-5072.
68. Xu, S.J.; Chen, S.; Zhang, M.H.; Shen, T. Synthesis, characterization and photodynamic activity of phenmethylamino-demethoxyhypocrellin B. J. Photochem. Photobiol. B:Biol., 2003, 72, 61-67.
69. Song, Y. Z.; An, J.Y.; Jiang, L.J. ESR and UV-Vis studies of semiquinone radical anion and hydroquinoe generated by 15- deacetyl-13-glycine-subsituted hypocrellin B. Free Radic. Res., 1999, 31, 477-486.
70. Zhao, Y.W.; Xie, J.; Zhao, J.Q. Photodynamic activity and potential usability of 14-carboxyl hypocrellin B. New J. Chem., 2003, 27, 880-885.
71. Zhao, Y.W.; Zhao, J.Q. Preparation of a novel hypocrellin derivative and its photochemical, photophysical properties. Dyes Pigm., 2004, 63, 175-179.
72. He, Y.Y.; An, J.Y.; Jiang, L.J. Photodynamic action of a watersoluble hypocrellin derivative with enhanced absorptivity in the phototherapeutic window I. ESR and UV-vis studies on the generation of semiquinone anion radical and hydroquinone. J. Photochem. Photobiol. A:Chem., 1998, 115, 213-221.
73. Liu, X.; Gu, Y.; Zhang, L.Y.; Chen, H.X.; Gu, Y.; Zhao, J.Q. A novel hypocrellin B derivative designed and synthesized basing on consideration to both drug delivery and biological PDT activity. J. Photochem. Photobiol. B: Biol., 2009, 94, 171-178.
74. Zhao, J.Q.; Liu, X.; Xie, J.; Gu, Y.; Chen, H.X.; Zhang, L.Y. Preparation and application of ω-amino-sulphonic hypocrellins. CN. Patent 200810101218.0, 2008.
75. Jain, R.K.; Duda, D.G.; Batchelor, T.T. In Angiogenesis: An Integrative Approach from Science to Medicine; William D. Figg, Judah Folkman, Ed.; Springer: New York, 2008; pp. 267-75.
76. Rajkumar S.V.; Mesa, R.A.; Tefferi, A. A Review of Angiogenesis and Anti-Angiogenic Therapy in Hematologic Malignancis. J. Hematother. Stem Cell Res., 2002, 11, 33-47.
77. Kanda, S.; Miyata, Y.; Kanettake, H.; Smithgall, T.E. Non-receptor protein-tyrosine kinases as molecular targets for antiangiogenic therapy (review). Int. J. Mol. Med., 2007, 20, 113-121.